chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After I got the vaccination on 02/10/2021 I got sick with chills, fever, body ache like I had the Flu which I expected it but on 02/11/2021 I almost fainted and 02/13/2021 I was feeling dizzy and it started progressing very bad, I was so dizzy that I couldn't walk. I contacted my doctor, I got an appointment and explained what happened because I couldn't get rid of my dizziness and the popping in my ears. The popping went away but dizziness is still there and I still have to deal with it. There nothing much I can do. I think I went back to the doctor the end of August because I was still dizzy, I was referred to see Neurologist and he said that everything looked fine and now I have an appointment with ENT this Friday because I'm still dealing with the dizziness. I have notice that when I walk I lean to the right side and is not making any sense so I really want to know what's going on. I do know this has something to do with the vaccine. I do believe that this 2nd dose gave me vertigo. Much better now but still dizzy and I don't know what to do. I really want to get the booster but what if I get worse then the 2nd dose? I'm kind of scared.
Sharp pain in my temple, eye and a black spot in my vision. Terrible migraines along with the sharp pains in the temple.   It just continued to progress and the pain and the black spot continued to grow.
swelling and inflammation of left leg/ankle/foot, extreme pain and difficulty walking, chronic fatigue, ongoing and recurring inflammation and swelling in left leg/ankle/foot to this day.  Checked for blood clots, there were none. Elevating left leg offers temporary relief of swelling but does not relieve pain and stiffness.
(03/25/2022) Patient was seated while vaccine was administered 0900 left deltoid. Immediate reaction noted after administration of vaccine. Nurse walked to dispose of sharp into the sharps container when nurse noticed Patient starting to fall towards her right side. Nurse rushed to catch volunteer before falling on the floor. Caught head; potential right side head trauma. Patient lost consciousness for less than 15 seconds. Medical Emergency Team (MET) was called immediately and arrived in less than one minute of incident. Upon arrival of MET team, Patient was conscious. Obtained vitals - initial vitals 0914 -BP 113/53 HR: 41 ; BP: 113/53 HR 56 ; 0920 -BP: 121/66 HR: 73. Patient declined ED visit twice. Informed patient to follow up with primary regarding potential right side head trauma. Informed patient to call family member to come and pick her up.   10:04 Patient stated she felt a little dizzy when standing up. Asked patient if she wanted to go to ED to get seen. Patient opted for Urgent Care. Patient stated she will go to Urgent Care to be seen. Patient stated that her mother was at facility to pick her up. Took patient last vitals at 01130 BP:129/58 HR:71. Patient stated she had a headache. Wheelchair to car transfer. After the incident, patient stated she fainted in the past from vaccinations. Patient stated it did not happen recently therefore did not feel that it was necessary to disclose the information to the vaccinator.
Pentacel expired on 4/22/23. No symptoms at all. Pt. was recalled to come in
Child started having minor tensing of the legs and arms in the begging of October whitch we thought were just baby quirks, it is now believed to have been minor seizures. They continued to get worse until in mid November she was constantly crying and tensing every few hours. She received another set of shots on 12/01/04. On 12/3/04 I was at my doctor's office when she had a spell, my doctor seen it and said it was seizures, by this time they were so bad that she was either asleep or having a seizure. My doctor sent us over to her doctor who put her on Femabarbitol.By 12/20/04 they were still present and we were sent to a hospital. A follow up appointment was made for 1/3/05 at this visit she was put on Lamictal wih some seizures still present. On 1/06/05 she was hospitalized to start Dilantin because of out of control seizure frequency. On 1/14/05 she was started on Ativan because frequency of seizures was still high. She is currently on Lamictal and Dilantin. Her 2 month well check on 2/28/04 shows we had rolls over one way,communicates by cooing, grasps small objects, watches objects moved across in front of face, and brings hands together. She no longer have rolls over and she is just now trying to do the other things again. Her 4 month well check on 12/1/04 shows she holds head steady when upright,laughs out loud,no head lag, raises chest while on stomach using arms for support,lifts head to 90 degree angle while on stomach, bears weight on legs when held in standing position,follows ob jects moved side to side, along with her acheivements showed on her 2 month well check. She is currently in Physical and occupational therapy to try to restablish these things she no longer does. She has very bad head lag and doesn't crawl and holds her hands in fists along with the lists of things above from her 2 well checks that she no longer does. I have medical records to support these details. Medical records received on 3/11/2005 states infection. Delayed development, on seizure meds.
Chest pain (not the angina I experienced prior to CABG 7.5 years ago) Shortness of breath, particularly when bending over Feelings of having a fast-beating, fluttering, or pounding heart
Complained of feeling feverish, queasy and nauseous since after receiving rabies vaccine. Complained of pain at injection site, states much more sore than previous vaccination. Denied any serious problems or severe allergic reaction.
I detected high blood pressure while at an eye doctor"s office--He had me verify it at my primary care physicians office same day.  I have never had high blood pressure--always normal or even a little low.
Initial report received from a healthcare professional on 03 January 2014. A 50-year-old female patient had received an intramuscular dose of FLUZONE (batch number, UH910AA, expiry date; 30 June 2014 and does number was not reported) in the left deltoid on 02 January 2014. The patient had no illness at time of vaccination and had a medical history of asthma. Concomitant medications were not reported. On 02 January 2014, same day of vaccination, the patient experienced tightness in the chest, unknown if the tightness was constant or comes and goes. No laboratory tests were performed and corrective treatments were not reported. At the time of this report, the outcome was unknown. List of documents held by sender: none.  Follow-up information was received from healthcare professional on 11 August 2014. It was reported that the patient was recovered from event (date unspecified). Documents held by sender: none.
Information has been received from a registered nurse concerning a 3 year old male patient with no known drug allergies or pertinent medical history who on 05-AUG-2009 was vaccinated subcutaneously in his left arm with the dose of 0.5 mL VARIVAX (Merck) (Lot # was 663810/0476Y). There was no concomitant medication. On 12-AUG-2009 the patient was lethargic with a fever of up to 102.8F off and on for 2 days after administration VARIVAX (Merck). The patient was treated with TYLENOL. After the patient was afebrile his right side of his mouth, eye and face hurt for 4 days. The patient sought medical attention and made an office visit. The result of dilated eye examination with Fluorescein staining was normal. On 18-AUG-2009, the patient recovered from these events. Follow-up information has been received from the nurse concerning the male patient with one sibling. It was reported that the patient developed a fever of 102.8 degrees F for 2 1/2 days. Subsequently the fever subsided then the patient complained of his right eye hurting and right side of his face/mouth possible tic type behavior. Symptoms lasted four days then resolved on 20-AUG-2009 (previously reported as 18-AUG-2009). No other family members developed fever/illness. These events required emergency room/doctor visit. Additional information has been requested.
Leg swelling - really noticeable 4 days after; Metallic taste; Heavy menstrual bleeding; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left leg on 05May2021 at 15:15 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not know of any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included paracetamol/ ibuprofen (ADVIL DUAL ACTION) for an unknown indication from an unknown date and unknown if ongoing. On 05May2021, the patient experienced metallic taste right after the shot and experienced heavy menstrual bleeding after shot. On 09May2021, the patient experienced leg swelling and was really noticeable 4 days after, which was on the day of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste right after the shot, heavy menstrual bleeding after shot and leg swelling was administered at left leg were unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Mild pain at injection site.; This is a spontaneous report from a non-contactable consumer (patient). A 52-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 23Feb2021 14:45 (Batch/Lot Number: EL3247) as single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. There were no concomitant medications. No covid prior vaccination. No covid tested post vaccination. On 24Feb2021 00:30, the patient experienced mild pain at injection site. No treatment received for AE. Outcome of the event was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
heavy chills at 4 am followed by the temperature.  The temperature went down in 2-3 days, but the headaches continued for about a week.
Pt received vaccine. On the next day he developed sudden onset of deafness of L ear, vomiting and vertigo.
Possible grandmal sz following vax (1st 24 hrs) unconsolable screaming;
dizziness; She experienced vertigo (badly) which lead to depth perception being off and she ran over her grand daughter; This is a spontaneous report from a contactable consumer (reporter's mother). A 69-years-old non pregnant female patient received bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on 19Aug2021 (at the age of 69-years-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history included kidney transplant. Patient had no known allergy. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Patient previously received first and second dose of bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. On an unspecified date, patient experienced vertigo (badly) which lead to depth perception being off and she ran over her granddaughter her doctors believe that her dizziness was from 3 vaccine. Therapeutic measures were taken as a result of dizziness and she experienced vertigo (badly) which lead to depth perception being off and she ran over her granddaughter and she received medication for vertigo. The outcome of al the events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
11/28/21 presents to ED for "chest tightness" "shortness of breath with exertion". PMHx of "anemia, triple negative breast cancer, diabetes mellitus type 2, hypertension"
received an expired dose of Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis.   On 02-JUN-2023, the patient received Kinrix. On 02-JUN-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: received an expired dose of Kinrix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-JUN-2023 The reporter consented to follow up via email. The patient received an expired dose of Kinrix, which led to expired vaccine used.
green stools following 2month and 4 month vaccines but also bloody stool (red streaks) for 2 occurrences following 4 month vaccine
This case was reported by a consumer via call center representative and described the occurrence of body temperature increased in a adult male patient who received SHINGRIX for prophylaxis. On 21st March 2019, the patient received SHINGRIX. On 21st March 2019, less than a day after receiving SHINGRIX, the patient experienced body temperature increased and heart rate increased. On an unknown date, the outcome of the body temperature increased and heart rate increased were unknown. It was unknown if the reporter considered the body temperature increased and heart rate increased to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient normally had low body temperature of 96 to 97 degrees F. On the day of reporting (later in the evening) after receiving SHINGRIX the patient's body temperature was elevated to 99.2 degrees F and the pulse rate was increased from the 60 to the 80. The reporter did not consent to follow up.
Migraines, at least, 2 to 3 times a day, every day for about a month following the second vaccination.  The migraines have slowed down to 1 about every 2 days now.
scrotal swelling  and pain - onset about 12-18 hours after vaccination and then anaphylaxis type symptoms (angioedema, throat swelling, shortness of breath, hives, lightheadedness, nausea) about 24-36 hours after vaccination requiring epinephrine injection; lip swelling improved but not fully resolved but no further anaphylaxis in the ED and sent home with script for Epipen
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (My husband had a sore arm after receiving the third dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION SITE PAIN (My husband had a sore arm after receiving the third dose). In 2021, VACCINATION SITE PAIN (My husband had a sore arm after receiving the third dose) had resolved.            No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-358998 (Patient Link).
Patient received Proquad on 11-3-06. Child had fever 11-4-06 of 101F Tylenol and Motrin given. Mother stopped Tylenol on Sunday; child had no fever. 11-6-06 Child at day care developed temp 102.1F child cranky and sleeping and no appetite. Monday child shivering wanted blanket, stiffened up, child confused. Temp 105.6 at hospital. Tylenol supp given.
presyncope requiring extended monitoring time, BP 93/53 with visual changes which resolved upon lying down, no ED visit, no syncope, self-limited
Irritability, fever to touch. Apparently asleep. 3-4 jerking movements of arms and one leg. Then limp and unresponsive for 5 min. Acetaminophen suppository. Responsive within seconds.
1:35 PT C/O FEELING FAINT. PLACED ON STRETCHER. PALE,DOAPHORETIC, DENIED NAUSEA. STATES HE ONLY HAD SMOOTHIE ALL DAY TO EAT. COLD, WET CLOTH TO HEAD. PLACED FLAT INBED. 134/86 HR 85 O2 97%.  Given H20 PO and tol well.     1:40 142/87  hr 84  o2 96%.  feels better.Sitting on side of stretcher. No longer diaphoretic and   color better. 1:55p  143/86  hr 77  o2 97%. sitting in chair. 2:05  feels fine. disch ambulatory.
MOM CALLED, REPORTED CHILD ?? ON RIGHT LEG THAT SHOTS WERE GIVEN.  NURSE INSTRUCTED TO TAKE CHILD TO ER FOR DOCTOR'S EVALUATION AND NOTIFY CLINIC FOR FOLLOW-UP.  MOM STATED CONTACTED PCP STATED TO GIVE MOTRIN AND OBSERVE. IMPROVING PER MOM.
No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry).    No concomitant medication was reported.  No treatment medication was reported.  The vial size was of 5.5 mL and was initially stored in the refrigerator on 12-Nov-2021.  The vial did not undergo any temperature excursions. The patient received the first booster dose of Moderna vaccine on 12-Nov-2021.
Patient felt dizzy blood pressure was taken at 2 minute intervals (80/60, 90/70, and 110/70) Patient felt fine after 10 minutes and left. She was pale and confused but was alert and oriented after departure.
Rec'd message to follow up for RN.   Dept/Mgr:  Rehab Resolution of Symptoms: n/a Covid-19 Vaccine Yes/No:   Yes     Date of last dose:   1/8/2021 Notes: Pt states on Wed 8/25, had mild sore throat.  Developed fever 8/26 with congestion, runny nose, chills.  Got tested yest am 8/26/2021,  à positive.  Instructed to continue to quarantine, await further instructions. Instructed to call back hotline when released from quarantine for further RTW guidance.  See email below. Informed that Pt tested positive for COVID-19, specimen collected 8/26/21. Vaccinated on 12/19/20 and 1/8/21 (Pfizer)  Last day of work was 8/25/21.  Patient reported that symptoms began on the evening of 8/25 after she got home from work. She first had a mild sore throat, followed by a 103F fever, chills, head congestion, runny nose. She denies body aches, loss of taste/smell, nausea, vomiting, diarrhea.   She denies any recent large gatherings, or sick contacts. She runs and works out outdoors around her neighborhood. She and her husband recently vacationed from 8/21-8/23. They did not mingle with anyone else during their trip. They hiked but she said it wasn?t that crowded.   At work, she has been primarily assigned to COVID patients and she always wears an N95 and eye protection for all patient encounters. However, her patients do not wear a mask during therapy because it makes them short of breath.  She eats lunch with a small group of physical and speech therapists at the plexiglass picnic tables. Staff is pulling their names for me. She either walks to work or her husband drops her off.   Pt lives with her husband who works remotely. He also had a mild sore throat starting on 8/25 but didn?t get tested.    Pt gives consent to disclose her name for contact tracing purposes. Employee worked on 8/24 & 8/25 from 8am-4:30pm while infectious.
During the night of June 23, 2022, I awoke with a really bad headache, took TYLENOL and it subsided. I awoke on the next night with headache and sore throat. I took a COVID-19 that came up positive. I decided to go to the local hospital testing site to confirm my positive result. I was advised to contact my primary care physician to get PAXLOVID, I contacted them once I got home. I got a call back and they let me know they had prescribed the PAXLOVID and I could pick it up and start it immediately. I took a reduced amount of PAXLOVID per NP instruction as there could be side effects with my heart medication.
Vaccination adverse reaction; chills; fever of 100.3 degrees Fahrenheit; pain on the left shoulder joint; panic attack; blood pressure is 180/103; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (panic attack), BLOOD PRESSURE INCREASED (blood pressure is 180/103), VACCINATION COMPLICATION (Vaccination adverse reaction), CHILLS (chills) and PYREXIA (fever of 100.3 degrees Fahrenheit) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included ALPRAZOLAM (XANAX) for an unknown indication.    On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced PANIC ATTACK (panic attack), BLOOD PRESSURE INCREASED (blood pressure is 180/103), CHILLS (chills), PYREXIA (fever of 100.3 degrees Fahrenheit) and ARTHRALGIA (pain on the left shoulder joint). On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, PANIC ATTACK (panic attack), BLOOD PRESSURE INCREASED (blood pressure is 180/103), VACCINATION COMPLICATION (Vaccination adverse reaction), CHILLS (chills), PYREXIA (fever of 100.3 degrees Fahrenheit) and ARTHRALGIA (pain on the left shoulder joint) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood pressure measurement: 80/103 mmhg (High) 180/103 mmHg. In 2021, Body temperature: 100.3 (High) 100.3 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    treatment to the events not reported. The patient reported "I called my insurance nurse line and was allowed to take my anxiety meds".   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow up contains updated event outcomes.
Information has been received from a physician concerning a female patient who was vaccinated against chicken pox with a dose of varicella virus vaccine live. Recently, in approximately 2003, the patient developed lesions after being exposed to a person who had chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information from the reporter indicated patient not known. No further information is expected.